Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Genomic Medicine |
RCV002508753 | SCV002818104 | uncertain significance | Aicardi-Goutieres syndrome 2 | 2021-05-20 | criteria provided, single submitter | clinical testing | [ACMG/AMP: PM2, PM3] This alteration is absent from or rarely observed in large-scale population databases [PM2] and is detected in trans with a known pathogenic variant [PM3]. |
Labcorp Genetics |
RCV002508753 | SCV004297238 | uncertain significance | Aicardi-Goutieres syndrome 2 | 2023-06-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 1810198). This variant has been observed in individual(s) with RNASEH2B-related conditions (PMID: 24183309). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change falls in intron 4 of the RNASEH2B gene. It does not directly change the encoded amino acid sequence of the RNASEH2B protein. |